UT Southwestern Medical Center became the first in Texas and the surrounding region to successfully perform a novel whole liver chemotherapy procedure using the FDA-approved Hepzato Kit to treat metastatic uveal melanoma, a rare and deadly form of eye cancer that commonly spreads to the liver. This breakthrough approach isolates liver circulation to deliver high-dose chemotherapy directly to tumors, aiming to improve disease control and survival for patients with few treatment options.